XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Note 5 - Intangible Assets
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]

NOTE 5 INTANGIBLE ASSETS

 

Finite-lived Intangible Assets

 

The components of intangible assets were as follows:

 

  

As of June 30, 2023

             As of December 31, 2022 
  

Gross Carrying
Costs

  

Accumulated
Amortization

  

Net Carrying
Amount

  

Gross Carrying
Costs

  

Accumulated
Amortization

  

Impairment

  

Net Carrying
Amount

 

Patents & Trademarks

 $535,096  $(268,913) $266,183  $509,141  $(255,276

)

 $-  $253,865 

Developed Technology

  -   -   -   3,500,000   (386,459

)

  (3,113,541

)

  - 

Customer Relationships

  -   -   -   200,000   (22,083

)

  (177,917

)

  - 

Tradename

  -   -   -   80,000   (22,083

)

  (57,917

)

  - 

Total

 $535,096  $(268,913) $266,183  $4,289,141  $(685,901

)

 $(3,349,375

)

 $253,865 

 

Amortization expense, recorded within general and administrative expenses, was $7,035 and $103,366 during the three months ended June 30, 2023 and 2022, respectively, and $13,700 and $206,890 during the six months ended June 30, 2023 and 2022, respectively.

 

The following table outlines the estimated future amortization expense related to intangible assets held as of June 30, 2023:

 

Year ending December 31,

 

Expense

 

Remainder of 2023

 $13,726 

2024

  27,451 

2025

  27,451 

2026

  27,451 

2027

  27,451 

Thereafter

  142,653 

Total

 $266,183 

 

The Company recognized no impairment of its finite-lived intangible assets during the three and six months ended June 30, 2023 and 2022.

 

Goodwill

 

As of June 30, 2022, the Company concluded that the goodwill acquired in connection with the acquisition of zPREDICTA Inc., the Company’s former wholly owned subsidiary, was fully impaired and recognized an impairment loss on goodwill of $7,231,093 during the three and six months then ended. As of June 30, 2023, the cumulative impairment of goodwill recorded was $7,231,093.

 

The goodwill acquired by the Company in connection with the acquisition of Helomics was zero as of both June 30, 2023 and December 31, 2022. The cumulative impairment of goodwill recorded was $23,790,290.